Hi ,

Celebrate Excellence in Life Sciences – Submit Your Nominations for the Pantheon Awards!

We are proud to be an industry supporter of the prestigious California Life Sciences 2024 Pantheon Awards, a hallmark event that honors outstanding achievements and contributions in the life sciences sector. This gala event brings together leaders, innovators, and visionaries who are making significant strides in advancing healthcare, biotechnology, and medical technology.

We invite you to nominate exceptional individuals and organizations who have made impactful contributions to our industry. This is your chance to highlight the changemakers driving innovation and improving lives.

Nomination Categories Include:

• Academia, Non-profit, & Research

• BioPharma

• Emerging Innovation

• Champion of Health Equity

• And more!

Nomination Deadline: 8/15

Don’t miss the opportunity to recognize and celebrate excellence in life sciences.

Submit your nominations today!

Submit here: https://bit.ly/46cauTx 

Join us in celebrating the future of healthcare innovation!

📢 Early Bird Tickets Sold Out! Just 1 Month Until The Nucleate Alumni Summit 🎟️

The enthusiasm from this community has been tremendous, with all early bird tickets for the Nucleate Alumni Summit sold out! But don't worry if you missed out—regular tickets are now available.

With just one month to go, the excitement is building for an event filled with insightful sessions, valuable networking opportunities, and an incredible lineup of keynote speakers and panel discussions. You won't want to miss it!

We’re looking forward to attending the Alumni Summit, so join us there and be part of something special!

👉 Purchase Tickets here: https://lu.ma/nucleatesummit

SynBioBeta Webinar and Podcast Series:

We want to provide you with even more multimedia content, like webinars and podcasts, bringing together industry thought leaders alongside the latest startup technologies. Are you interested in hosting a webinar or podcast? Do you have a great topic you'd like to learn about? Are there guests you'd love to see present? Please take a moment to share your thoughts with us. It only takes about 60 seconds!! Click here and give us your thoughts! 

Latest Videos From SynBioBeta 2024:

• AI and SynBio: The New Paradigm in Drug Discovery. The explosion of artificial intelligence has impacted every aspect of our lives. For synthetic biology, these algorithms enable us to synthesize and design solutions for some of our world's most significant challenges in previously impossible ways.

• The Scale-Cost Paradox: Navigating Biomanufacturing's Biggest Challenge. As latent demand for sustainable bioproducts grows, the biomanufacturing industry stands at a crossroads.

• Crafting Cures: How Synthetic Biology Personalizes Precision Medicine. Step into a world where biology meets innovation, where we no longer rely solely on what nature provides but proactively design it.

Insights:

• Artificial Intelligence Reveals Protein-DNA Interactions. Protein structure prediction has improved significantly in recent years, but predicting their interactions with DNA will be vital to realizing their applications.

Industry News:

• Antheia Secures $17 Million to Boost U.S. Production of Critical Pharmaceutical Ingredients: This funding will support the onshoring of pharmaceutical ingredient production to the United States and accelerate Antheia's commercialization efforts.

Dr. Christina Smolke, Antheia CEO and co-founder, at SynBioBeta 2023.

• GRObio Secures $60.3 Million in Series B Financing to Advance Protein Therapeutics: This funding will enhance its genomically recoded organism (GRO) platform for scalable production of therapeutics using multiple non-standard amino acids (NSAAs)

• Kurita America and Solugen Join Forces to Develop Carbon-Negative Water Treatment Products. This partnership aims to introduce high-performance, bio-based alternatives to phosphorus and other petroleum-derived additives currently used in the market.

• GSK Partners with Touchlight for mRNA Vaccine Development Using dbDNA Technology. Touchlight grants GSK non-exclusive rights to use its enzymatic dbDNA technology to accelerate mRNA vaccine production.

• 'AnoxyGen' Grant Boosts Anaerobic Bacteria Research and Biotechnology. The ERC Advanced Grant supports Hertweck's "AnoxyGen" project, highlighting its promise in expanding microbial biosynthesis knowledge and biotechnological applications.

• Bacterial Memory: A New Frontier in Probiotic Engineering. Beneficial bacteria's memory paves the way for improved agricultural and industrial applications, thanks to groundbreaking research from Reichman University.

• Hitched to Lipid Rafts: Targeting Cells with Surgical Precision. A groundbreaking study from Northwestern University reveals a new technique to deliver engineered proteins to specific cells, revolutionizing targeted biological drug delivery.

Additional Industry News:

• Designer fats startup Nourish Ingredients collaborates with dairy giant Fonterra on fats from fermentation. Nourish will work with Fonterra on Creamilux, a lipid produced by a genetically engineered microbe that “recreates the rich, creamy mouthfeel, taste and emulsification properties of dairy fat.” (AgFunder News)

Regards

Jeff

Jeffrey S. Buguliskis, PhD

Director of Content, SynBioBeta

Who's hiring?

• Science Manager & Carbon Capture Venture Tech Lead at Novonesis (Lyngby, Denmark)

• Chief of Staff to COO at Maverick BioMetals (San Antonio, TX)

• Associate Account Executive at LatchBio (San Francisco, CA) 

• Head of Informatics at Colorifix (Norwich or Cambridge)

• Centre Manager at Bezos Centre for Sustainable Protein (London, UK)

• Head of Growth, Innovation, and Impact at Bezos Centre for Sustainable Protein (London, UK)

• Communications and Marketing Lead at Bezos Centre for Sustainable Protein (London, UK)

• Lecturer/Senior Lecturer/Reader/Professor at Bezos Centre for Sustainable Protein (London, UK)